WuXi Biologics (Cayman) Inc. (WXIBF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 02:12PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 7.44B |
| Enterprise Value | 6.51B |
| Trailing P/E | 15.33 |
| Forward P/E | 11.39 |
| PEG Ratio (5 yr expected) | 0.76 |
| Price/Sales (ttm) | 3.01 |
| Price/Book (mrq) | 1.22 |
| Enterprise Value/Revenue | 0.38 |
| Enterprise Value/EBITDA | 1.18 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.62 |
| 52-Week Change 3 | -74.17% |
| S&P500 52-Week Change 3 | 22.38% |
| 52 Week High 3 | 6.6000 |
| 52 Week Low 3 | 1.6300 |
| 50-Day Moving Average 3 | 1.9582 |
| 200-Day Moving Average 3 | 4.1271 |
Share Statistics
| Avg Vol (3 month) 3 | 23.76k |
| Avg Vol (10 day) 3 | 7.48k |
| Shares Outstanding 5 | 4.16B |
| Implied Shares Outstanding 6 | 4.56B |
| Float 8 | 3.62B |
| % Held by Insiders 1 | 14.18% |
| % Held by Institutions 1 | 41.21% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 3:1 |
| Last Split Date 3 | Dec 10, 2020 |
Financial Highlights
Currency in CNY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 19.96% |
| Operating Margin (ttm) | 19.09% |
Management Effectiveness
| Return on Assets (ttm) | 4.63% |
| Return on Equity (ttm) | 8.90% |
Income Statement
| Revenue (ttm) | 17.03B |
| Revenue Per Share (ttm) | 4.09 |
| Quarterly Revenue Growth (yoy) | 6.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 4.93B |
| Net Income Avi to Common (ttm) | 3.4B |
| Diluted EPS (ttm) | 0.1100 |
| Quarterly Earnings Growth (yoy) | -39.90% |
Balance Sheet
| Total Cash (mrq) | 11.24B |
| Total Cash Per Share (mrq) | 2.66 |
| Total Debt (mrq) | 4.56B |
| Total Debt/Equity (mrq) | 10.36% |
| Current Ratio (mrq) | 2.78 |
| Book Value Per Share (mrq) | 9.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.67B |
| Levered Free Cash Flow (ttm) | -320.31M |
© 2024 Yahoo. All rights reserved.